PINSHAN Biotech develops filtration membranes and chromatography resins—critical consumables used in biopharmaceutical manufacturing. The company is focused on advancing R&D of core bioprocess materials and scaling manufacturing capacity. It plans to commercialize upstream solutions for biologics production and to meet growing local demand. PINSHAN recently partnered with Repligen Corporation to locally manufacture hollow fiber filtration products. The company raised nearly RMB 100 million in a Series A to fund its R&D, capacity expansion, and commercialization efforts. The articles position PINSHAN as part of broader efforts to strengthen China’s bioprocess supply chain.

Total raised

$15M

Funding rounds

1

Latest round

Series A

Latest activity

Jul 2026